Tower Resources completes Neptune farm-out agreement
Oil and gas company Tower Resources said Thursday all conditions relating to the farm-out agreement bewteeen its subsidiary Neptune Petroleum and Arcadia Expro Namibia and Repsol Exploration were completed.
Oil and gas company Tower Resources said Thursday all conditions relating to the farm-out agreement bewteeen its subsidiary Neptune Petroleum and Arcadia Expro Namibia and Repsol Exploration were completed.
As part of the agreement, Neptune released escrow funds of $5.3m to reimburse Arcadia for 30% of the costs on the licence. Neptune will assume 30% of costs from July.
Repsol has a majority stake of licence 0010 with a 44% interest. Tower holds 30% while Arcadia has a 26% ownership.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
"We are pleased that the agreements have now been completed," said Tower's Chief Executive Officer, Graeme Thomson.
"We look forward to updating the market as preparations are progressively made to drill the Welwitschia well on the multi-billion barrel prospect, formerly identified as the Delta structure.
He said planning for the well was underway and five potential reservoirs were identified within the structure.
Shares climbed 1.05% to 2.40p at 12:39 Thursday.
RD
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
What the Employment Rights Bill means for your job
New workplace reforms are set to give employees new rights to benefits and flexible working
By Marc Shoffman Published
-
GSK share price surges after $2.2bn Zantac drug settlement
GSK has settled lawsuits in the US that alleged the drugmaker’s now-discontinued heartburn drug Zantac triggered cancer
By Chris Newlands Published